Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,472.05
+39.90 (2.79%)
At close: Feb 9, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 204 billion as of February 9, 2026. Its market cap has increased by 18.34% in one year.
Market Cap
204.00B
Enterprise Value
231.27B
Revenue
29.86B
Ranking
n/a
PE Ratio
49.15
Stock Price
1,472.05
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 204.00B, an increase of 146.66%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 204.00B | -0.53% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 421.12B |
| J. B. Chemicals & Pharmaceuticals | 297.06B |
| AstraZeneca Pharma India | 214.54B |
| Jubilant Pharmova | 147.91B |
| Caplin Point Laboratories | 138.78B |
| Granules India | 136.94B |
| Rubicon Research | 129.27B |
| CORONA Remedies | 94.02B |